{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T19:41:21Z","timestamp":1776627681008,"version":"3.51.2"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Taiwan\u2019s Ministry of Science and Technology","doi-asserted-by":"crossref","award":["106-2320-B-002-032-MY3"],"award-info":[{"award-number":["106-2320-B-002-032-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.chest.2019.12.006","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T19:33:06Z","timestamp":1577475186000},"page":"1117-1129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting \u03b22-Agonist Combinations in Patients With COPD"],"prefix":"10.1016","volume":"157","author":[{"given":"Ting-Yu","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Yien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Hsuen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaa-Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9064","key":"10.1016\/j.chest.2019.12.006_bib1","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.chest.2019.12.006_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200707-973OC","article-title":"The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol\/fluticasone propionate or tiotropium bromide","volume":"177","author":"Wedzicha","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2019.12.006_bib4","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2147\/COPD.S116750","article-title":"The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study","volume":"11","author":"Wang","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.chest.2019.12.006_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12931-015-0210-x","article-title":"Comparative effectiveness of budesonide\/formoterol combination and fluticasone\/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study","volume":"16","author":"Kern","year":"2015","journal-title":"Respir Res"},{"key":"10.1016\/j.chest.2019.12.006_bib6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","article-title":"Inhaled corticosteroids in COPD and the risk of serious pneumonia","volume":"68","author":"Suissa","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2019.12.006_bib7","doi-asserted-by":"crossref","first-page":"f3306","DOI":"10.1136\/bmj.f3306","article-title":"Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting beta2 agonist: observational matched cohort study (PATHOS)","volume":"346","author":"Janson","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.chest.2019.12.006_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00037-2017","article-title":"The risk of mycobacterial infections associated with inhaled corticosteroid use","volume":"50","author":"Brode","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2019.12.006_bib9","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2147\/COPD.S139035","article-title":"Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist","volume":"12","author":"Yang","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"8","key":"10.1016\/j.chest.2019.12.006_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2019.12.006_bib11","first-page":"CD010115","article-title":"Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease","volume":"3","author":"Kew","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.chest.2019.12.006_bib12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2147\/COPD.S128358","article-title":"Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies","volume":"12","author":"Hollis","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.chest.2019.12.006_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(80)90363-0","article-title":"The problem of \u201cprotopathic bias\u201d in case-control studies","volume":"68","author":"Horwitz","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.chest.2019.12.006_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.03.003","article-title":"The lag-time approach improved drug-outcome association estimates in presence of protopathic bias","volume":"78","author":"Arfe","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.chest.2019.12.006_bib15","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1378\/chest.118.4.1042","article-title":"Effects of high-dose inhaled fluticasone propionate via spacer on cell-mediated immunity in healthy volunteers","volume":"118","author":"Sharma","year":"2000","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.chest.2019.12.006_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2165\/00003088-200342060-00003","article-title":"Deposition and effects of inhaled corticosteroids","volume":"42","author":"Newman","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.chest.2019.12.006_bib17","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4187\/respcare.06290","article-title":"Aerosol delivery devices for obstructive lung diseases","volume":"63","author":"Pleasants","year":"2018","journal-title":"Respir Care"},{"issue":"9","key":"10.1016\/j.chest.2019.12.006_bib19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/thx.2007.086041","article-title":"Patient adherence in COPD","volume":"63","author":"Bourbeau","year":"2008","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.chest.2019.12.006_bib20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1378\/chest.15-0627","article-title":"Discontinuation of inhaled corticosteroids in COPD and the risk reduction of pneumonia","volume":"148","author":"Suissa","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.chest.2019.12.006_bib21","first-page":"721","article-title":"Validating the adapted Diabetes Complications Severity Index in claims data","volume":"18","author":"Chang","year":"2012","journal-title":"Am J Manag Care"},{"issue":"8","key":"10.1016\/j.chest.2019.12.006_bib22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2337\/dc08-0138","article-title":"Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study","volume":"31","author":"Kornum","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.chest.2019.12.006_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2015-000181","article-title":"Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients","volume":"4","author":"Martins","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.chest.2019.12.006_bib24","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2147\/COPD.S115137","article-title":"Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease","volume":"11","author":"Lin","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"10.1016\/j.chest.2019.12.006_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"issue":"6","key":"10.1016\/j.chest.2019.12.006_bib26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul C"},{"key":"10.1016\/j.chest.2019.12.006_bib27","series-title":"Survival Analysis: State of the Art","article-title":"Cox-type regression analysis for large numbers of small groups of correlated failure time observations","author":"Lee","year":"1992"},{"key":"10.1016\/j.chest.2019.12.006_bib28","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2147\/COPD.S143656","article-title":"Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD","volume":"12","author":"Janson","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.chest.2019.12.006_bib29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bcp.12637","article-title":"Inhaled corticosteroids: potency, dose equivalence and therapeutic index","volume":"80","author":"Daley-Yates","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.chest.2019.12.006_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0954-6111(98)90434-6","article-title":"Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide","volume":"92","author":"Boobis","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.chest.2019.12.006_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1465-9921-10-104","article-title":"The bioavailability and airway clearance of the steroid component of budesonide\/formoterol and salmeterol\/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial","volume":"10","author":"Dalby","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.chest.2019.12.006_bib32","doi-asserted-by":"crossref","first-page":"j3772","DOI":"10.1136\/bmj.j3772","article-title":"Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets","volume":"358","author":"Leung","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.chest.2019.12.006_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12890-017-0571-7","article-title":"Burden of asthma and COPD overlap (ACO) in Taiwan: a nationwide population-based study","volume":"18","author":"Shantakumar","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"7","key":"10.1016\/j.chest.2019.12.006_bib34","doi-asserted-by":"crossref","first-page":"864","DOI":"10.5588\/ijtld.14.0327","article-title":"Asthma and COPD overlap syndrome is associated with increased risk of hospitalisation","volume":"19","author":"Kim","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"10.1016\/j.chest.2019.12.006_bib35","first-page":"431","article-title":"Asthma-COPD overlap syndrome showed more exacerbations however lower mortality than COPD","volume":"110","author":"Bai","year":"2017","journal-title":"QJM"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219344551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219344551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:17:11Z","timestamp":1757924231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369219344551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0012369219344551"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2019.12.006","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting \u03b22-Agonist Combinations in Patients With COPD","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2019.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}